Biological response modifiers (BRM), chemotherapy, and activated cytotoxic leukocyte subsets: strategies for rational design of apheresis-based cancer immunotherapies.
作者信息
Stevenson H C, Klein H G
机构信息
National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.